Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

New bleeding combo for hip surgery shows promise

NCT ID NCT07610863

Disease control Sponsor: St. Anne's University Hospital Brno, Czech Republic Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study looked at whether giving tranexamic acid (a medicine that reduces bleeding) both through an IV and directly into the hip joint during hip replacement surgery can safely lower blood loss. 58 adults having elective hip replacement took part. The goal was to see if the combined method works better than IV alone without raising the risk of blood clots.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

58 people

The number who actually took part.

Started

Jun 2024

Finished

Jul 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

Children (under 18), adults (18 to 64) and older adults (65 and over)

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Adults undergoing elective primary cementless total hip arthroplasty for primary hip osteoarthritis * Preoperative hemoglobin level ≥130 g/L * Ability to provide written informed consent Exclusion Criteria: * Post-traumatic or secondary hip arthritis * Known allergy or hypersensitivity to tranexamic acid * History of deep vein thrombosis or pulmonary embolism * Current anticoagulant therapy * Known coagulation disorder * Body mass index (BMI) \>40 kg/m² * Significant hepatic or renal dysfunction * Type 1 diabetes mellitus * Significant cardiovascular disease * Traumatic indication for total hip arthroplasty

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coagulation monitoring using rotem are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

osteoarthritis, hip

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Coagulation monitoring using rotem Perioperative blood loss Total hip arthroplasty Tranexamic acid administration

Contacts and locations

Locations

  • First Department of Orthopaedic Surgery, St. Anne's University Hospital and Faculty of Medicine, Masaryk University, Brno, Czechia

    Brno, Czechia, 60200, Czechia

More trials for these conditions

Other studies related to the condition(s) this trial covers.